Abstract:Background : Clostridium difficile is considered to be the main pathogen responsible for hospital-acquired infections in western countries, but few studies on C. difficile have been carried out in China. This study performed a prospective study to describe the prevalence, molecular epidemiological characteristics and risk factors of Clostridium difficile infection (CDI) and Clostridium difficile colonization (CDC) among patients in intensive care units (ICUs), with the aim of providing strategies for efficient CD prevention and control.Methods: Stool samples were collected from adult patients on admission to an 18-bed ICU department, and were anaerobically cultured for C. difficile . The identified isolates were tested for toxin genes, followed by multilocus sequence typing to analyze the genotypes. Patients were divided into CDI, CDC and control groups according to clinical features. The medical records of these groups were collected and further analyzed using logistic regression to investigate the risk factors.Results: Of the 800 patients included in the study, 33 (4.12%) and 25 (3.12%) patients were identified with CDI and CDC, respectively. An association was found between CDI patients and having a fever (OR=13.993) or metabolic disorder (OR=7.972), and treatment with fluoroquinolone (OR=42.696) or a combination of antibiotics (OR=2.856). CDC patients were characterized by longer hospital stays (OR=1.137), an increased number of comorbidities (OR=36.509), respiratory diseases (OR=0.043) and treatment with vancomycin (OR=18.168). However, treatment with metronidazole was simultaneously found to be a protective factor in the two groups (OR=0.042; OR=0.013). Eighteen sequence types (STs) were identified. Among the CDI group, the isolates were predominantly toxin A- and toxin B-positive (A+B+) strains and genotype ST-2 was the epidemic clone. In the CDC group, the dominant strains were A+B+ and ST-81 was the epidemic clone.Conclusions: The prevalence of C. difficile colonization and infection in our ICU patients was relatively high, suggesting the importance of routine screening to detect the acquisition of this pathogen. Future prevention and treatment strategies for C. difficile -related disease should take into consideration the duration of hospital stays, enteral nutrition, underlying comorbidities, as well as the use of combined antibiotics. Moreover, metronidazole could be a protective factor for both CDI and CDC.

Risk Factors, Outcomes and Epidemiology Associated with Clostridium Difficile Infection in Patients with Haematological Malignancies in a Tertiary Care Hospital in China

Clinical Risk Factors For Clostridium Difficile Infection In A Chinese Tertiary Care Hospital

A Case of Multiple Recurrence of Clostridium Difficile Infection with Severe Hematochezia in an Immunocompromised Host

Molecular Epidemiology of Clostridium Difficile in A Tertiary Hospital of China

Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009–2016) retrospective study in a large university hospital

Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China

Risk Factors of Clostridium Difficile Infections among Patients in a University Hospital in Shanghai, China.

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China

Molecular Characterization and Antibiotic Resistance of Clostridioides Difficile in Patients with Inflammatory Bowel Disease from Two Hospitals in China

Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.

Molecular Epidemiology and Antimicrobial Susceptibility of Clostridium Difficile Isolated from Hospitals During a 4-Year Period in China.

Risk factors for Clostridium difficile infection and colonization among patients admitted to intensive care units in Shanghai, China

Risk Factors for Clostridioides Difficile Infection and Colonization among Patients Admitted to an Intensive Care Unit in Shanghai, China

Clostridium Difficile Colonization and Infection in Patients with Hepatic Cirrhosis

Risk Factors for Clostridium Difficile Infection in Cirrhotic Patients.

Longitudinal Investigation of Carriage Rates and Genotypes of Toxigenic Clostridium Difficile in Hepatic Cirrhosis Patients.

Clostridium Difficile Infection among Hospitalized Chronic Hepatitis B Virus-Infected Patients in a Chinese Hospital

Clinical and Microbiological Characterization of Clostridium Difficile Infection in a Tertiary Care Hospital in Shanghai, China.

Molecular Epidemiology and Risk Factors of <i>Clostridium difficile</i> ST81 Infection in a Teaching Hospital in Eastern China

Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study